German Study Hints Diabetes Drug Cuts Alzheimer's Risk

A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away. Earlier studies have suggested that people and animals given the widely used pill for type-2 diabetes, called pioglitazone, were less likely to develop Alzheimer's or other forms of dementia. The medicine is sold under the brand name Actos by...

© La Voix de l'Amérique - lundi 14 juillet 2014